Prophylactic surgery rates among men with breast cancer nearly double
the ONA take:
The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011, which mirrors a trend seen in women with breast cancer, according to a report from American Cancer Society and Dana Farber Cancer Institute researchers.
In women, particularly younger women, use of CPM has increased over the past two decades despite a lack of evidence for survival benefit, associated costs, and possible complications. Breast cancer in men accounts for approximately 1% of all cases in the United States.
The researchers pulled nationwide data from the North American Association of Central Cancer Registries on 6,332 men who underwent surgery for breast cancer limited to one breast between 2004 and 2011.
Rate of CMP among men increased from 3.0% in 2004 to 5.6% in 2011. The sociodemographic factors linked to more surgery in men were similar to those for women who underwent CPM: being white, younger age, and having private insurance.
However, the study did not have data on other factors linked to women who choose to undergo CPM, such as genetic testing, family history, magnetic resonance imaging, or fear of breast cancer occurring in the other breast.
The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|